Clinical Research Studies
We do research across every area of cardiovascular care. Our research offers hope for patients, options to discuss with your doctor, and opportunities to make a difference for future patients. See the search below for a list of our active and enrolling clinical research studies and see if you may qualify to participate.
Benefits of Research
Be More Active
Take a more active role in your own health care.
Potential to Unlock More Options
You may gain access to investigational treatments and medications.
Make a Contribution
Help find a new and better way to treat people with your condition.
Search for research studies
EMPACT MIStudy Investigator:
Marc Newell, MD
About the Study:This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying from cardiovascular disease. Condition:
NSTEMI/STEMI (Heart Attack)
|
View Study |
Spirit 48: ABT NG DES 48Study Investigator:
Nicholas Burke, MD
About the Study:The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions. Condition:
Coronary Artery Disease
|
View Study |
ZEUSStudy Investigator:
Courtney Jordan Baechler, MD
About the Study:This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example, heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation. Participants will either receive ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). This is known as the study medicine. Which treatment a participant receives is decided by chance. Participant's chance of getting ziltivekimab or placebo is the same. Condition:
Other
|
View Study |
TREOStudy Investigator:
Xiaoyi Teng, MD
About the Study:The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms. Condition:
Other
|
View Study |
Target IVStudy Investigator:
Jay Traverse, MD
About the Study:The aim of the TARGET-IV NA trial is to demonstrate the clinical non-inferiority of the Firehawk® rapamycin eluting stent system in comparison to currently approved 2nd generation DES for the treatment of subjects with ischemic heart disease (NSTEMI, recent STEMI (>24 hours from initial presentation and in whom enzyme levels have peaked), unstable angina, and stable coronary disease), with atherosclerotic target lesion(s) in coronary arteries with visually estimated reference vessel diameters ≥2.25 mm and ≤4.0 mm. Condition:
Coronary Artery Disease
|
View Study |